GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
38.24
+0.53 (1.41%)
Aug 12, 2025, 4:00 PM - Market closed
GSK Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for GSK.
Price Target: $ (0.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for GSK stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +38.60% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +22.91% | May 30, 2024 |
Financial Forecast
Revenue This Year
33.12B
from 31.38B
Increased by 5.56%
Revenue Next Year
34.81B
from 33.12B
Increased by 5.08%
EPS This Year
1.73
from 0.62
Increased by 178.25%
EPS Next Year
1.92
from 1.73
Increased by 10.93%
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.1B | 37.7B | 41.6B | ||
| Avg | 33.1B | 34.8B | 36.3B | ||
| Low | 30.7B | 31.9B | 33.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.9% | 13.7% | 19.4% | ||
| Avg | 5.6% | 5.1% | 4.4% | ||
| Low | -2.1% | -3.6% | -5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.89 | 2.18 | 2.50 |
| Avg | 1.73 | 1.92 | 2.05 |
| Low | 1.46 | 1.61 | 1.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 203.4% | 26.0% | 30.2% |
| Avg | 178.2% | 10.9% | 6.6% |
| Low | 134.6% | -7.0% | -13.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.